Skip to main content

Home/ OARS funding Behavior/ Group items tagged drugs

Rss Feed Group items tagged

MiamiOH OARS

PAR-18-226: Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders... - 0 views

  •  
    Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. NIDA has developed two Avenir Award Programs, one for HIV/AIDS research and the other for genetics or epigenetics studies.
    The Genetics or Epigenetics of Substance Use Disorders Avenir Award program supports early stage investigators proposing highly innovative studies that open new areas of research for the genetics or epigenetics of addiction. These may be novel methods or approaches that can potentially be applied to the analysis of the genetics or epigenetics of addiction. Investigators outside the field of addiction interested in applying their novel approaches to the genetics or epigenetics of addiction are encouraged to apply. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field of genetics or epigenetics of substance use disorders.
MiamiOH OARS

PAR-18-224: NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) - 0 views

  •  
    This Funding Opportunity Announcement (FOA) is to provide support for research Centers that
    (1) conduct drug abuse and addiction research in any area of NIDA's mission,

    (2) have outstanding innovative science,

    (3) are multidisciplinary, thematically integrated, synergistic, and

    (4) serve as national resource(s) to provide educational and outreach activities to drug abuse research communities, educational organizations, the general public, and policy makers in the NIDA research fields
    It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are required. The P50 Center of Excellence is expected to foster the career development and mentoring of new investigators who would be given meaningful roles to play in the Center projects. A goal of this program is to create NIDA Centers that are national community resources for furthering drug abuse research by sharing their findings, their data, and their resources as appropriate for researchers to use and build upon and to advance research in this field
MiamiOH OARS

Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Op... - 0 views

  •  
    The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing the innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to study the etiology and epidemiology of drug using behaviors (defined as alcohol, tobacco, prescription and other drug) and related disorders, prevention of drug use and HIV, and health service utilization. This FOA encourages the analyses of public use and other extant community-based or clinical datasets to their full potential in order to increase our knowledge of etiology, trajectories of drug using behaviors and their consequences including morbidity and mortality, risk and resilience in the development of psychopathology, strategies to guide the development, testing, implementation, and delivery of high quality, effective and efficient services for the prevention and treatment of drug abuse and HIV.
MiamiOH OARS

Drug Early Warning Signals from High Risk Populations - 0 views

  •  
    The Office of National Drug Control Policy (ONDCP), Executive Office of the President, is seeking applications from public nonprofit institutions/organizations (includes institutions of higher education and hospitals) to perform research and analysis of data to inform drug policy. This project seeks to further refine a methodology for obtaining drug early warning indicators from expanded testing of urine samples that were previously collected and tested as part of an existing drug test protocol. This method was initially developed using local criminal justice populations - including persons in pre-trial or lock-up, parolees or probationers, and drug court participants. In addition, this method was also tested in two trauma units, with promising results. This project will use similar methodology in criminal justice, health care, and other venues, to include opioid treatment admissions, trauma units or emergency departments, and criminal justice programs such as parole or probation, where biological samples are often collected from clients.
MiamiOH OARS

Supplement to CDC-RFA-CE16-1608: Enhanced State Surveillance of Opioid-Involved Morbidi... - 0 views

  •  
    1) link Prescription Drug Monitoring Program (PDMP) information to opioid-related drug overdose deaths, 2) complete abstraction and entry of information from death certificate and ME/C reports on opioid-related fatalities into the State Unintentional Drug Overdose Reporting System (SUDORS) within 3 to 6 months, 3) improve scope and/or data quality collected on emergency department (ED) drug overdose visits, 4) improve timeliness and reporting of emergency medical services (EMS) data, and/or 5) propose innovative projects that fall within the scope of the ESOOS cooperative agreement and are approved by CDC.
MiamiOH OARS

Supplement to CDC-RFA-CE16-1606 Prescription Drug Overdose: Data-Driven Prevention Init... - 0 views

  •  
    The purpose of this funding is to expand funded states’ ability to advance and evaluate state-level prevention for opioid overuse, misuse, abuse, and overdose in states with a high burden of drug overdose deaths. The original FOA (CDC-RFA-CE16-1606) advanced a two-tiered strategy to allow for the fact that the needs of states vary considerably. Some states need support to build their ability to collect, analyze, and apply data and develop a strategy to combat the epidemic. These states were funded for the Planning and Data (base) component alone. Other states need resources and support to implement a comprehensive prevention program. These states were funded for both the Planning and Data component and the Prevention in Action (enhanced) component. States funded under the Planning and Data (base) component are expected to improve their data collection and analysis around the epidemic and work with their communities to develop a strategy for building a larger, more comprehensive program in the future
1 - 6 of 6
Showing 20 items per page